Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Carboplatin 3Radiotherapy, Intensity-Modulated 2Radiotherapy 2selinexor 1ponatinib 1poly ICLC 1pemigatinib 1neratinib 1donafenib 1cobimetinib 1ceritinib 1cemiplimab 1brigatinib 1abemaciclib 1Thymopentin 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiation 1Pluvicto 1Platinum Compounds 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Neck Dissection 1NF protocol 1Magnetic Resonance Spectroscopy 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma × (225)Ac-DOTA-c(RGDyK) × Clear all
NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡